Treatment with an interleukin-1 receptor antagonist protein prolongs mouse islet allograft survival.
par Sandberg, J O;Eizirik, Decio L. ;Sandler, S;Tracey, D E;Andersson, A.
Référence Diabetes (New York, N.Y.), 42, 12, page (1845-1851)
Publication Publié, 1993
Référence Diabetes (New York, N.Y.), 42, 12, page (1845-1851)
Publication Publié, 1993
Article révisé par les pairs
Titre: |
|
Auteur: | Sandberg, J O; Eizirik, Decio L.; Sandler, S; Tracey, D E; Andersson, A. |
Informations sur la publication: | Diabetes (New York, N.Y.), 42, 12, page (1845-1851) |
Statut de publication: | Publié, 1993 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Animals |
Blood Glucose -- metabolism | |
Diabetes Mellitus, Experimental -- surgery | |
Graft Survival -- drug effects | |
Graft Survival -- physiology | |
Infusions, Intravenous | |
Interleukin 1 Receptor Antagonist Protein | |
Interleukin-1 | |
Islets of Langerhans Transplantation -- pathology | |
Islets of Langerhans Transplantation -- physiology | |
Kidney | |
Mice | |
Mice, Inbred C57BL | |
Sialoglycoproteins -- administration & dosage | |
Sialoglycoproteins -- pharmacology | |
Time Factors | |
Transplantation, Heterologous | |
Transplantation, Homologous | |
Transplantation, Isogeneic | |
Note générale: | Journal Article |
Langue: | Anglais |
Identificateurs: | urn:issn:0012-1797 |
info:pmid/8243831 |